OLIVERO, Martina

OLIVERO, Martina  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.048 secondi).
Titolo Data di pubblicazione Autore(i) File
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells 2018 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1. 2000 De Sanctis L; Romagnolo De Sanctis C; Lala R; Olivero M; Di Renzo MF; Dianzani I.
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. 2009 Maniscalco L.; De Maria R.; Iussich S.; Martín De Las Mulas J.; Olivero M.; Millán Y; Biolatti B.
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 2009 Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin 2010 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway 2011 Olivero M; Dettori D; Pavan S; Di Renzo MF
Genetics in renal cancer 2008 M. Olivero; A. Lorenzato; Di Renzo MF
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel 2012 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
Identification of Actionable Cancer Genes and Treatment Options for Metastatic Ovarian Carcinomas using Patient Derived Xenografts (PDXs) and PDX Derived Tumor Cells (PDTCs) 2018 Concetta D’Ambrosio, Martina Olivero, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Enrico Berrino, Tiziana Vanesio, Stefania Bolla, Giorgio Valabrega, Raffaele Calogero and Maria Flavia Di Renzo
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis 2012 Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 2009 Raffaella De Maria; Silvia Miretti; Selina Iussich; Martina Olivero;Emanuela Morello; Andrea Bertotti; James G. Christensen; Bartolomeo Biolatti; Roy A. Levine; Paolo Buracco; Maria Flavia Di Renzo
MET-oncogene transforms human bone-derived cells by targeting committed progenitors. 2010 Dani N; Olivero M; Lorenzato A; Cuvertino S; Patane’ S; Van Duist M; Mareschi K; Fagioli F; Di Renzo MF
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS 2010 N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF
Molecular characterization and activation of AKT oncogene in feline mammary tumors 2009 Maniscalco Lorella; Raffaella De Maria ; Selina Iussich ; Minelli Carla; Olivero Martina; Sasaki Nobu; Bartolomeo Biolatti
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 2006 RAFFAELLA DE MARIA; SILVIA MIRETTI; SELINA IUSSICH; MARTINA OLIVERO; MARIA FLAVIA DI RENZO; PAOLO BURACCO; BARTOLOMEO BIOLATTI
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer 2007 Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF
Quantitative HER2/neu gene expression in feline mammary tumors 2004 RAFFAELLA DE MARIA; SELINA IUSSICH; MARTINA OLIVERO; TOMAOKI MURATA; B. BIOLATTI; MASSIMO CASTAGNARO; BARTOLOMEO BIOLATTI
Results of 149 mobile bearing postero-stabilized TKA at average of 7 years follow-up: analysis of prognostic factors influencing outcomes. 2016 Rosso F, Cottino U, Olivero M, Dettoni F, Bruzzone M, Bonasia DE, Rossi R
Shortening of the bones of the hand in genetically characterized PHP-la patients. 2002 De Sanctis L; Romagnolo D; Andreo MR; Olivero M; Dianzani I; De Sanctis C.
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C 2011 Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF